首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1601806

消費者基因組學市場 - 全球產業規模、佔有率、趨勢、機會和預測，按應用、地區和競爭細分，2019-2029F

Consumer Genomics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Application, By Region and Competition, 2019-2029F

出版日期: 2024年11月30日 | 出版商:

TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年全球消費者基因組市值為12.6億美元，預計2029年將達到36.7億美元，預測期間內複合年成長率為19.68%。全球消費者基因組學市場已成為醫療保健、遺傳學和個人化健康領域的一股變革力量，為個人提供了前所未有的獲取遺傳資訊和了解其血統、健康傾向和特徵的機會。這個新興市場的特點是提供直接面對消費者 (DTC) 的基因檢測服務，在基因組技術進步、測序成本下降以及消費者對遺傳學的認知和興趣不斷提高的推動下，該市場呈指數級成長。該市場涵蓋廣泛的產品，從血統和譜系測試到健康和保健評估、藥物基因組學和以生活方式為導向的遺傳見解。

市場概況
預測期	2025-2029
2023 年市場規模	12.6億美元
2029 年市場規模	36.7億美元
2024-2029 年複合年成長率	19.68%
成長最快的細分市場	生活方式健康與營養
最大的市場	北美洲

這些測試通常涉及收集唾液或臉頰拭子樣本，然後進行分析以產生綜合報告，詳細說明血統組成、疾病的遺傳傾向、遺傳狀況的攜帶者狀態以及對某些藥物的反應。除了滿足人們對遺傳的好奇心之外，消費者基因組學對醫療保健也具有重大影響，有助於積極主動的疾病預防、個人化治療策略以及有關生活方式選擇、營養和健身方案的明智決策。

遺傳資料與數位健康平台、穿戴式裝置和遠距醫療服務的整合，為針對個人遺傳圖譜量身定做的個人化醫療方法鋪平了道路，從而徹底改變了傳統的醫療保健範式。然而，消費者基因組學的廣泛採用引發了倫理、隱私和監管方面的擔憂，涉及基因資料的保密性和安全性、測試結果的準確性和解釋、遺傳風險披露的潛在心理影響以及透過測試實現基因組資訊的商業化。例如，2022 年10 月，韓國GC Biopharma 的子公司GC LabTech（經過CAP 和ISO 認證的FDA 註冊專業實驗室，專門挽救生命的血漿測試）選擇了1health.io，這是一家改變產業格局的先鋒軟體公司透過將服務擴展到國內市場，促進將其尖端實驗室測試直接交付給消費者，從而擴大實驗室測試的影響力。

消費者基因組學公司、製藥公司、研究機構和醫療保健提供者之間的合作正在促進創新並推動精準腫瘤學、罕見疾病診斷和人口健康管理等領域新穎應用的開發。新興市場消費者基因組學的普及以及對個人化醫療解決方案不斷成長的需求，將推動市場進一步擴張，並推動未來幾年的持續成長。

主要市場促進因素

基因組技術和定序方法不斷取得進展

消費者對遺傳學、健康和保健的興趣和意識不斷成長

消費者基因體學與數位健康科技的融合

主要市場挑戰

駕馭監管環境

確保資料隱私和安全

解決道德和社會影響

主要市場趨勢

技術進步

個性化醫療保健的擴展

細分市場洞察

應用洞察

區域洞察

Global Consumer Genomics Market was valued at USD 1.26 billion in 2023 and is expected to reach USD 3.67 Billion by 2029 with a CAGR of 19.68% during the forecast period. The Global Consumer Genomics Market has emerged as a transformative force in healthcare, genetics, and personalized wellness, offering individuals unprecedented access to their genetic information and insights into their ancestry, health predispositions, and traits. This burgeoning market, characterized by the provision of direct-to-consumer (DTC) genetic testing services, has witnessed exponential growth driven by advancements in genomic technologies, declining sequencing costs, and increasing consumer awareness and interest in genetics. The market encompasses a wide array of offerings, ranging from ancestry and genealogy tests to health and wellness assessments, pharmacogenomics, and lifestyle-oriented genetic insights.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 1.26 Billion
Market Size 2029	USD 3.67 Billion
CAGR 2024-2029	19.68%
Fastest Growing Segment	Lifestyle Wellness & Nutrition
Largest Market	North America

These tests typically involve the collection of a saliva or cheek swab sample, which is then analyzed to generate comprehensive reports detailing ancestry composition, genetic predispositions to diseases, carrier status for genetic conditions, and response to certain medications. Beyond satisfying curiosity about one's genetic heritage, consumer genomics has significant implications for healthcare, facilitating proactive disease prevention, personalized treatment strategies, and informed decision-making regarding lifestyle choices, nutrition, and fitness regimens.

The integration of genetic data with digital health platforms, wearable devices, and telemedicine services has paved the way for personalized medicine approaches tailored to individual genetic profiles, thereby revolutionizing traditional healthcare paradigms. However, the widespread adoption of consumer genomics has raised ethical, privacy, and regulatory concerns regarding the confidentiality and security of genetic data, the accuracy and interpretation of test results, potential psychological impacts of genetic risk disclosures, and the commercialization of genomic information by testing companies. For instance, In October 2022, GC LabTech, a subsidiary of GC Biopharma based in South Korea, a CAP & ISO accredited FDA-registered specialty laboratory specializing in life-saving plasma tests, chose 1health.io, a pioneering software company transforming the landscape of laboratory testing by extending services to the at-home market, to facilitate the delivery of its cutting-edge laboratory tests directly to consumers.

Collaborations between consumer genomics companies, pharmaceutical firms, research institutions, and healthcare providers are fostering innovation and driving the development of novel applications in areas like precision oncology, rare disease diagnosis, and population health management. Expanding access to consumer genomics in emerging markets and the growing demand for personalized healthcare solutions are poised to fuel further market expansion and drive sustained growth in the coming years.

Key Market Drivers

Growing Progress in Genomic Technologies and Sequencing Methodologies

The Global Consumer Genomics Market is experiencing a significant boost from the growing progress in genomic technologies and sequencing methodologies, which are driving unprecedented advancements in genetic testing accessibility, affordability, and accuracy. One of the primary drivers of market growth is the emergence of next-generation sequencing (NGS) platforms, which have revolutionized the field of genomics by enabling high-throughput, cost-effective sequencing of large volumes of genetic data. Unlike traditional Sanger sequencing methods, NGS technologies leverage parallel sequencing of millions of DNA fragments, significantly reducing sequencing costs and turnaround times. This technological breakthrough has democratized access to genetic testing, allowing consumer genomics companies to offer comprehensive DNA analysis at a fraction of the cost, making it accessible to a broader segment of the population.

Advancements in sequencing methodologies, such as whole-genome sequencing (WGS) and whole-exome sequencing (WES), have expanded the scope and depth of genetic analysis, enabling the identification of rare variants, structural variations, and complex genetic interactions associated with disease risk and treatment response. These techniques provide consumers with a more comprehensive view of their genetic makeup, enhancing the utility and value of consumer genomics products and services.For instance, In 2021, myDNA, a prominent Australian genomics company, revealed its merger with the U.S.-based consumer DNA testing company FamilyTreeDNA and its parent organization, Gene by Gene, headquartered in Houston.

The development of miniaturized, portable sequencing devices and point-of-care testing platforms is further driving market growth by enabling real-time, on-demand genetic testing in diverse settings, including clinics, pharmacies, and even home environments. These handheld devices offer rapid sample-to-answer capabilities, making genetic testing more convenient, accessible, and scalable, particularly in remote or underserved regions where access to traditional laboratory-based testing facilities may be limited.

Advancements in bioinformatics and data analysis algorithms are enhancing the interpretation and actionable insights derived from genetic data, enabling consumer genomics companies to provide more personalized and accurate reports to consumers. Machine learning and artificial intelligence (AI) techniques are being increasingly utilized to analyze vast genomic datasets, identify disease associations, and predict individual health risks, further driving the adoption of consumer genomics for personalized healthcare and wellness management.

Growing Consumer Interest and Awareness of Genetics, Health, And Wellness

The Global Consumer Genomics Market is experiencing a significant boost from the growing consumer interest and awareness of genetics, health, and wellness, driving increased demand for personalized genetic testing and insights. In recent years, there has been a notable shift in consumer attitudes towards healthcare, with individuals becoming more proactive in managing their health and seeking personalized solutions based on their genetic makeup. One of the primary drivers of market growth is the increasing public awareness of the role genetics plays in health and disease. With the rise of personalized medicine and the growing body of research linking genetic variants to various health conditions, consumers are increasingly recognizing the value of genetic testing in understanding their individual health risks and making informed decisions about preventive measures and treatment options. Media coverage, educational campaigns, and celebrity endorsements have also contributed to raising awareness of consumer genomics, making genetic testing more mainstream and accessible to a broader audience.

The popularity of direct-to-consumer (DTC) genetic testing services offered by companies like 23andMe, AncestryDNA, and MyHeritage has fueled consumer interest in exploring their genetic ancestry, traits, and predispositions to diseases. These companies offer easy-to-use DNA testing kits that enable individuals to collect a saliva or cheek swab sample at home and receive comprehensive reports detailing their ancestry composition, genetic health risks, carrier status for inherited conditions, and other genetic insights. The convenience, affordability, and privacy of DTC genetic testing have contributed to its widespread adoption among consumers seeking to unlock the secrets of their genetic code.

The growing focus on preventive healthcare and wellness optimization has spurred interest in leveraging genetic information to tailor lifestyle choices, nutrition plans, and fitness regimens to individual genetic profiles. Consumers are increasingly turning to consumer genomics to gain insights into their genetic predispositions for traits like metabolism, response to exercise, and dietary preferences, empowering them to make informed decisions about their health and well-being. This growing demand for personalized wellness solutions is driving market expansion and diversification, with consumer genomics companies offering a wide range of health and wellness-oriented genetic tests and services to cater to diverse consumer needs and preferences.

Convergence Of Consumer Genomics with Digital Health Technologies

The convergence of consumer genomics with digital health technologies is playing a pivotal role in boosting the Global Consumer Genomics Market, driving innovation, and expanding the scope of personalized healthcare delivery. This synergy between genomics and digital health is revolutionizing the way genetic information is collected, analyzed, and utilized to empower individuals in managing their health and well-being. One of the key drivers of market growth is the integration of genetic data with electronic health records (EHRs) and other digital health platforms, enabling seamless interoperability and data sharing between healthcare providers and consumer genomics companies. This integration facilitates the incorporation of genetic information into routine healthcare workflows, allowing clinicians to access and interpret genetic test results alongside other clinical data to inform diagnosis, treatment decisions, and disease management strategies. By leveraging digital health technologies, consumer genomics companies can enhance the clinical utility and relevance of genetic testing, thereby driving adoption among healthcare professionals and improving patient outcomes.

Wearable devices and mobile health applications are increasingly being utilized to collect real-time health data, lifestyle behaviors, and environmental factors, which can be integrated with genetic information to provide more holistic and personalized health insights to consumers. Wearable sensors, such as fitness trackers, smartwatches, and biosensors, enable continuous monitoring of physiological parameters like heart rate, activity levels, sleep patterns, and stress responses, complementing genetic data to offer a comprehensive view of an individual's health status and risk factors. By combining genetic and lifestyle data, consumer genomics companies can deliver more tailored and actionable recommendations for disease prevention, wellness optimization, and behavior modification, empowering individuals to take control of their health.

Advancements in big data analytics and artificial intelligence (AI) are enabling consumer genomics companies to extract valuable insights from vast genomic datasets, identify disease associations, and predict individual health risks with greater accuracy and specificity. Machine learning algorithms can analyze genetic variations, biomarkers, and clinical data to generate personalized risk assessments, treatment recommendations, and lifestyle interventions tailored to individual genetic profiles.

Key Market Challenges

Navigating Regulatory Landscape

One of the foremost challenges hindering the Global Consumer Genomics Market is navigating the complex regulatory landscape governing genetic testing and data privacy. Regulatory frameworks vary significantly across different regions and countries, creating compliance challenges for consumer genomics companies operating in multiple jurisdictions. The evolving nature of regulations, particularly regarding the classification and oversight of genetic tests by regulatory agencies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in the European Union, adds further complexity and uncertainty to market entry and expansion efforts.

Ensuring Data Privacy and Security

Data privacy and security concerns pose significant challenges to the Global Consumer Genomics Market, as the collection, storage, and analysis of genetic data raise ethical and legal considerations regarding the confidentiality and protection of sensitive information. Consumers are increasingly concerned about the risks of unauthorized access, misuse, or exploitation of their genetic data by third parties, including hacking, data breaches, and unauthorized sharing with employers, insurers, or law enforcement agencies. Consumer genomics companies must implement robust data encryption, access controls, and privacy policies to safeguard genetic information and earn the trust of consumers and regulatory authorities.

Addressing Ethical and Social Implications

The widespread adoption of consumer genomics raises ethical and social implications regarding the disclosure of genetic information, potential psychological impacts of genetic risk disclosures, and implications for personal identity, family relationships, and societal norms. Genetic testing results may reveal unexpected or sensitive information about individuals' health risks, ancestry, or paternity, leading to psychological distress, stigma, and discrimination. The commercialization of genetic data by testing companies and the commodification of genetic information raises concerns about equity, fairness, and societal implications of genetic profiling and discrimination based on genetic traits.

Key Market Trends

Technological Advancements

Over the past decade, there have been significant innovations in DNA sequencing techniques, leading to a dramatic reduction in sequencing costs, increased throughput, and improved accuracy. Next-generation sequencing (NGS) platforms have become more accessible and affordable, enabling consumer genomics companies to offer comprehensive genetic testing services at a fraction of the cost compared to traditional methods. Advancements in bioinformatics and data analysis algorithms are enhancing the interpretation of genetic data, providing more actionable insights into individuals' health risks, ancestry, and traits. Technological advancements are driving significant growth in the Global Consumer Genomics Market, revolutionizing the accessibility, affordability, and accuracy of genetic testing services. Over the past decade, breakthroughs in DNA sequencing technologies, particularly next-generation sequencing (NGS), have propelled the consumer genomics industry forward. NGS platforms have democratized access to genetic information by drastically reducing sequencing costs, increasing throughput, and improving scalability. This has enabled consumer genomics companies to offer comprehensive DNA testing services at lower prices, making genetic testing more accessible to a broader audience.

Advancements in bioinformatics and data analysis algorithms have enhanced the interpretation of genetic data, providing consumers with more actionable insights into their ancestry, health risks, and traits. Machine learning and artificial intelligence (AI) techniques are being increasingly utilized to analyze vast genomic datasets, identify disease associations, and predict individual health risks with greater accuracy and specificity. These technological advancements are driving innovation and expanding the scope of consumer genomics, paving the way for personalized healthcare solutions tailored to individual genetic profiles. As genomic technologies continue to evolve, consumer genomics is poised to play a pivotal role in shaping the future of preventive medicine, personalized healthcare, and wellness optimization on a global scale.

Expansion of Personalized Healthcare

The growing demand for personalized healthcare solutions is driving the expansion of the Global Consumer Genomics Market. With the rise of precision medicine and the increasing emphasis on preventive healthcare, consumers are seeking genetic testing services to gain insights into their genetic predispositions to diseases, response to medications, and optimal lifestyle choices. Consumer genomics companies are responding to this demand by diversifying their offerings to include a wide range of health and wellness-oriented genetic tests, including pharmacogenomics, nutrigenomics, and lifestyle assessments. This trend towards personalized healthcare is driving market growth and innovation, as consumers increasingly recognize the value of genetic information in optimizing their health and well-being. The expansion of personalized healthcare is a significant driver behind the growth of the Global Consumer Genomics Market. With the increasing emphasis on preventive medicine and the rise of precision healthcare, consumers are seeking genetic testing services to gain insights into their genetic predispositions to diseases, response to medications, and optimal lifestyle choices. This trend reflects a shift towards proactive health management, where individuals are empowered to take control of their health and make informed decisions based on their genetic makeup.

Consumer genomics companies are responding to this demand by diversifying their offerings to include a wide range of health and wellness-oriented genetic tests, including pharmacogenomics, nutrigenomics, and lifestyle assessments. By offering user-friendly DNA testing kits, online platforms for accessing genetic data, and personalized health reports, consumer genomics companies are empowering consumers to tailor their healthcare decisions to their unique genetic profiles. The expansion of personalized healthcare is driving market growth and innovation in the consumer genomics industry, as individuals increasingly recognize the value of genetic information in optimizing their health and well-being. As this trend continues to evolve, consumer genomics is poised to play a pivotal role in shaping the future of preventive medicine, personalized healthcare, and wellness optimization on a global scale.

Segmental Insights

Application Insights

Based on the application, genetic relatedness emerged as the dominant segment in the global consumer genomics market in 2023. This is due to the increasing consumer interest in understanding their genetic ancestry, familial relationships, and heritage. Consumers are intrigued by the prospect of uncovering their genetic roots and tracing their lineage through DNA testing, which has fueled the demand for ancestry and genealogy services offered by consumer genomics companies. Advancements in genetic sequencing technologies and data analytics have made it easier and more affordable for individuals to access and interpret their genetic information, further driving the growth of the Genetic Relatedness segment.

The lifestyle wellness & nutrition segment is anticipated to dominate the market in the forecast period on account of the growing consumer interest in personalized health and wellness solutions tailored to individual genetic profiles.

Regional Insights

North America emerged as the dominant player in the Global Consumer Genomics Market in 2023, holding the largest market share. This is primarily due to several factors contributing to the region's leadership in the consumer genomics industry. North America boasts a highly developed healthcare infrastructure and a strong emphasis on personalized medicine, driving widespread adoption of genetic testing services among consumers. The presence of key market players, such as 23andMe, AncestryDNA, and MyHeritage, located in North America, has significantly contributed to the region's market dominance.

Key Market Players

Positive Biosciences Limited
DNA N U Ltd.
Helix, Inc.
23andMe, Inc.
MyHeritage Ltd.
Pathway
Veritas Technologies LLC
Illumina, Inc.
Xcode Life
Toolbox Genomics

Report Scope:

In this report, the Global Consumer Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Consumer Genomics Market, By Application:

Genetic Relatedness
Diagnostics
Lifestyle Wellness & Nutrition
Ancestry
Personalized Medicine & Pharmacogenetic Testing
Sports Nutrition & Health
Other Application Types

Consumer Genomics Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Consumer Genomics Market.

Available Customizations:

Global Consumer Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Consumer Genomics Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Application (Genetic Relatedness, Diagnostics, Lifestyle Wellness, & Nutrition, Ancestry, Personalized Medicine & Pharmacogenetic Testing, Sports Nutrition & Health, Other Application Types)
- 5.2.2. By Company (2023)
- 5.2.3. By Region
5.3. Market Map

6. North America Consumer Genomics Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Application
- 6.2.2. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Consumer Genomics Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Application
- 6.3.2. Mexico Consumer Genomics Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Application
- 6.3.3. Canada Consumer Genomics Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Application

7. Europe Consumer Genomics Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Application
- 7.2.2. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Consumer Genomics Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Application
- 7.3.2. Germany Consumer Genomics Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Application
- 7.3.3. United Kingdom Consumer Genomics Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Application
- 7.3.4. Italy Consumer Genomics Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Application
- 7.3.5. Spain Consumer Genomics Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Application

8. Asia-Pacific Consumer Genomics Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Application
- 8.2.2. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Consumer Genomics Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Application
- 8.3.2. India Consumer Genomics Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Application
- 8.3.3. South Korea Consumer Genomics Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Application
- 8.3.4. Japan Consumer Genomics Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Application
- 8.3.5. Australia Consumer Genomics Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Application

9. South America Consumer Genomics Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Application
- 9.2.2. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Consumer Genomics Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Application
- 9.3.2. Argentina Consumer Genomics Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Application
- 9.3.3. Colombia Consumer Genomics Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Application

10. Middle East and Africa Consumer Genomics Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Application
- 10.2.2. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Consumer Genomics Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Application
- 10.3.2. Saudi Arabia Consumer Genomics Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Application
- 10.3.3. UAE Consumer Genomics Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Positive Biosciences Limited
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. DNA N U Ltd.
14.3. Helix, Inc.
14.4. 23andMe, Inc.
14.5. MyHeritage Ltd.
14.6. Pathway
14.7. Veritas Technologies LLC
14.8. Illumina, Inc.
14.9. Xcode Life
14.10. Toolbox Genomics